Impact of third-party reimbursement on cancer clinical investigation: a consensus statement coordinated by the National Cancer Institute.
McCabe
M
M
Friedman
M A
MA
D002986:Clinical Trials as Topic; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D007349:Insurance, Health, Reimbursement; D009369:Neoplasms / Q000188:drug therapy*; D014481:United States
D015507:Drugs, Investigational